With $90 million in funding, the Ginkgo spinoff Motif joins the fight for the future of food

Continuing its quest to become the Amazon Web Services for biomanufacturing, Ginkgo Bioworks has launched a new spinoff called Motif Ingredients with $90 million in funding to develop proteins that can serve as meat and dairy replacements. It’s the second spinout for Ginkgo since late 2017 when the company partnered with Bayer to launch Joyn […]

View More With $90 million in funding, the Ginkgo spinoff Motif joins the fight for the future of food

Gingko Bioworks secures $275 million in Series D, valuing the company at over $1 billion

 Boston biotech startup Gingko Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic. The company previously raised over $154 million, bringing the total up to… Read More

View More Gingko Bioworks secures $275 million in Series D, valuing the company at over $1 billion